AbbVie: Upadacitinib Phase 3, ABBV-295 Phase 2 Updates
AbbVie provided updates on its Upadacitinib Phase 3 trial and its ABBV-295 Phase 2 trial.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
AbbVie provided updates on its Upadacitinib Phase 3 trial and its ABBV-295 Phase 2 trial.